Some of the important publications in vascular liver diseases in Jan/Feb 2018

[Akash Shukla]

1. An Individualised Strategy and Long-Term Outcomes of Endovascular Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis.
Ding PX, He X, Han XW, Zhang Y, Wu Y, Liang XX, Liu C.
Eur J Vasc Endovasc Surg. 2018 Feb 22. pii: S1078-5884(17)30768-2. doi: 10.1016/j.ejvs.2017.12.016. [Epub ahead of print]
PMID: 29478911 [PubMed – as supplied by publisher]

2. Diagnosis, treatment and outcome of hepatic venous outflow obstruction in paediatric liver transplantation: 24-year experience at a single centre.
Galloux A, Pace E, Franchi-Abella S, Branchereau S, Gonzales E, Pariente D.
Pediatr Radiol. 2018 Feb 21. doi: 10.1007/s00247-018-4079-y. [Epub ahead of print]
PMID: 29468367 [PubMed – as supplied by publisher]

3. Benign and malignant hepatocellular lesions in patients with vascular liver diseases.
Vilgrain V, Paradis V, Van Wettere M, Valla D, Ronot M, Rautou PE.
Abdom Radiol (NY). 2018 Feb 19. doi: 10.1007/s00261-018-1502-7. [Epub ahead of print]
PMID: 29460040 [PubMed – as supplied by publisher]

4. Cirrhotic cardiomyopathy is less prevalent in patients with Budd-Chiari syndrome than cirrhosis of liver.
Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Phadke M, Rathod K, Meshram M, Bhatia SJ.
Indian J Gastroenterol. 2018 Jan 24. doi: 10.1007/s12664-017-0811-z. [Epub ahead of print]
PMID: 29368192 [PubMed – as supplied by publisher]

5. Hepatic sinusoidal dilatation.
Brancatelli G, Furlan A, Calandra A, Dioguardi Burgio M.
Abdom Radiol (NY). 2018 Feb 1. doi: 10.1007/s00261-018-1465-8. [Epub ahead of print]
PMID: 29392360 [PubMed – as supplied by publisher]

6. Endothelial JAK2^V617F does not enhance liver lesions in mice with Budd-Chiari syndrome.
Poisson J, Hilscher MB, Tanguy M, Hammoutene A, Boulanger CM, Villeval JL, Simonetto DA, Valla D, Shah VH, Rautou PE.
J Hepatol. 2018 Jan 31. pii: S0168-8278(18)30022-9. doi: 10.1016/j.jhep.2018.01.010. [Epub ahead of print] No abstract available.
PMID: 29360553 [PubMed – as supplied by publisher]

7. Numerical simulation of hemodynamics in membranous obstruction of the suprahepatic inferior vena cava based on a subject-specific Budd-Chiari syndrome model.
Cheng D, Zhuang Y, Kou Q, Zhang M, Zhao Y, Han C, Li J, Wang Y, Xu K, Mo F, Zhang J.
Clin Biomech (Bristol, Avon). 2018 Jan 2;52:20-24. doi: 10.1016/j.clinbiomech.2017.12.013. [Epub ahead of print]
PMID: 29316476 [PubMed – as supplied by publisher]

8. Prognostic scoring systems and outcome of endovascular radiological intervention of chronic Budd-Chiari syndrome in children.
Singh SK, Sen Sarma M, Yadav R, Kumar S, Prasad R, Yachha SK, Srivastava A, Poddar U.
Liver Int. 2018 Jan 3. doi: 10.1111/liv.13683. [Epub ahead of print]
PMID: 29297972 [PubMed – as supplied by publisher]

9. Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients.
Bianchini M, Cavani G, Bonaccorso A, Turco L, Vizzutti F, Sartini A, Gitto S, Merighi A, Banchelli F, Villa E, Schepis F.
Liver Int. 2018 Feb 22. doi: 10.1111/liv.13728. [Epub ahead of print]
PMID: 29469184 [PubMed – as supplied by publisher]

10. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
Merola J, Fortune BE, Deng Y, Ciarleglio M, Amirbekian S, Chaudhary N, Shanbhogue A, Ayyagari R, Rodriguez-Davalos MI, Teperman L, Charles HW, Sigal SH.
Eur J Gastroenterol Hepatol. 2018 Feb 16. doi: 10.1097/MEG.0000000000001097. [Epub ahead of print]
PMID: 29462027 [PubMed – as supplied by publisher]

11. Portal vein thrombosis: yes or no on anticoagulation therapy.
Turon F, Hernández-Gea V, García-Pagán JC.
Curr Opin Organ Transplant. 2018 Feb 9. doi: 10.1097/MOT.0000000000000506. [Epub ahead of print]
PMID: 29432256 [PubMed – as supplied by publisher]

12. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis.
Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O.
Dig Liver Dis. 2018 Jan 31. pii: S1590-8658(18)30168-3. doi: 10.1016/j.dld.2018.01.132. [Epub ahead of print]
PMID: 29429910 [PubMed – as supplied by publisher]

13. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
Kwon J, Koh Y, Yu SJ, Yoon JH.
Thromb Res. 2018 Feb 1;163:71-76. doi: 10.1016/j.thromres.2018.01.032. [Epub ahead of print]
PMID: 29407630 [PubMed – as supplied by publisher]

14. Liver Atrophy and Regeneration in Non-Cirrhotic Portal Vein Thrombosis: Effect of Surgical Shunts.
Elnaggar AS, Griesemer AD, Bentley-Hibbert S, Brown RS Jr, Martinez M, Lobritto SJ, Kato T, Emond JC.
Liver Transpl. 2018 Jan 29. doi: 10.1002/lt.25024. [Epub ahead of print]
PMID: 29377486 [PubMed – as supplied by publisher]

15. Gastrointestinal: Duodenal variceal bleeding secondary to thrombophilia-related portal vein thrombosis.
Mullish BH, Mathew S, Dhar A.
J Gastroenterol Hepatol. 2018 Feb;33(2):336. doi: 10.1111/jgh.13982. No abstract available.
PMID: 29372608 [PubMed – in process]

16. What Are the Benefits of Anticoagulation for Portal Vein Thrombosis in Individuals With Cirrhosis?
Wood CP, Rowe IA.
Gastroenterology. 2018 Feb;154(3):759-760. doi: 10.1053/j.gastro.2017.08.075. Epub 2018 Jan 17. No abstract available.
PMID: 29352956 [PubMed – in process]

17. Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: Not Only Recanalize the Portal Vein.
Chen H, Lv Y, Han G.
Gastroenterology. 2018 Feb;154(3):758-759. doi: 10.1053/j.gastro.2017.08.076. Epub 2018 Jan 17. No abstract available.
PMID: 29351835 [PubMed – in process]

18. Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients.
Qi X, Valla DC, Guo X.
Gastroenterology. 2018 Feb;154(3):760-761. doi: 10.1053/j.gastro.2017.09.057. Epub 2018 Jan 17. No abstract available.
PMID: 29351830 [PubMed – in process]

19. Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation.
Guillaume M, Christol C, Plessier A, Corbic M, Péron JM, Sommet A, Rautou PE, Consigny Y, Vinel JP, Valla CD, Bureau C.
Eur J Gastroenterol Hepatol. 2018 Jan 8. doi: 10.1097/MEG.0000000000001061. [Epub ahead of print]
PMID: 29315156 [PubMed – as supplied by publisher]

[Author]

Posts